Reuters logo
BRIEF-Sangui Biotech International posts Q1 revenues from royalty income and product sales of $10,000
October 13, 2016 / 1:26 PM / a year ago

BRIEF-Sangui Biotech International posts Q1 revenues from royalty income and product sales of $10,000

Oct 13 (Reuters) - Sangui Biotech International Inc

* Revenues from royalty income and product sales of $48 thousand in its fiscal year 2016 (as of June 30, 2016). In same period of previous year, comparable revenues amounted to $127 thousand

* Generated revenues from royalty income of approximately $10,000 during Q1 of fiscal year 2017

* FY operating loss decreased by $0.391 million to $0.361 million compared to previous year Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below